Regarding: Humar et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 2010;10:1228–1237

Caspar da Cunha-Bang, M Iversen, S A Mortensen, Allan Rasmussen, H Sengeløv, S S Sørensen, J Lundgren

2 Citations (Scopus)
Original languageEnglish
JournalAmerican Journal of Transplantation
Volume11
Issue number2
Pages (from-to)408
ISSN1600-6135
DOIs
Publication statusPublished - 1 Feb 2011

Cite this